| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Raquel Sabino | Q41183613 |
| P2093 | author name string | Paul Bowyer | |
| Malcolm Richardson | |||
| P2860 | cites work | Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study | Q89030870 |
| Assessment of human exposure to airborne fungi in agricultural confinements: personal inhalable sampling versus stationary sampling | Q24276124 | ||
| Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis | Q24650911 | ||
| Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions | Q24669852 | ||
| Analysis of fungal flora in indoor dust by ribosomal DNA sequence analysis, quantitative PCR, and culture | Q28383326 | ||
| Aspergillus, Penicillium and Talaromyces isolated from house dust samples collected around the world | Q28383582 | ||
| Diversity and Composition of Airborne Fungal Community Associated with Particulate Matters in Beijing during Haze and Non-haze Days | Q28392169 | ||
| Molecular profiling of fungal communities in moisture damaged buildings before and after remediation--a comparison of culture-dependent and culture-independent methods | Q28393306 | ||
| Fungal biodiversity--as found in nasal mucus | Q33188473 | ||
| Characterization of the oral fungal microbiome (mycobiome) in healthy individuals | Q33523794 | ||
| The oral fungal mycobiome: characteristics and relation to periodontitis in a pilot study. | Q33901380 | ||
| The role of the microbiome in exacerbations of chronic lung diseases | Q34199591 | ||
| The human gut mycobiome: pitfalls and potentials--a mycologist's perspective. | Q34493441 | ||
| Dispersal in microbes: fungi in indoor air are dominated by outdoor air and show dispersal limitation at short distances | Q34593499 | ||
| The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection | Q34710850 | ||
| Contrasting the microbiomes from healthy volunteers and patients with chronic rhinosinusitis | Q35029909 | ||
| The fungal microbiome in chronic rhinosinusitis: richness, diversity, postoperative changes and patient outcomes | Q35087142 | ||
| Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease | Q35618488 | ||
| Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. | Q36345291 | ||
| Fungus and chronic rhinosinusitis: from bench to clinical understanding. | Q36622952 | ||
| Metataxonomic and Metagenomic Approaches vs. Culture-Based Techniques for Clinical Pathology | Q36773761 | ||
| Aspergillus-associated airway disease, inflammation, and the innate immune response | Q37077782 | ||
| High diversity of airborne fungi in the hospital environment as revealed by meta-sequencing-based microbiome analysis | Q37550442 | ||
| Role of bacterial and fungal biofilms in chronic rhinosinusitis | Q37982957 | ||
| Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview | Q38079263 | ||
| Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces | Q38099051 | ||
| Microbial communities associated with house dust | Q39399627 | ||
| Invasive Fungal Infections in the Intensive Care Unit | Q39421603 | ||
| Variability of indoor fungal microbiome of green and non-green low-income homes in Cincinnati, Ohio | Q41571482 | ||
| City-scale distribution and dispersal routes of mycobiome in residences. | Q42242722 | ||
| Aeromycological profile of indoor and outdoor environments | Q43070775 | ||
| Culturomics and Amplicon-based Metagenomic Approaches for the Study of Fungal Population in Human Gut Microbiota | Q46249656 | ||
| Corticosteroid treatment is associated with increased filamentous fungal burden in allergic fungal disease | Q46264567 | ||
| Fungi in Bronchiectasis: A Concise Review | Q47558222 | ||
| The Human Mucosal Mycobiome and Fungal Community Interactions | Q47711287 | ||
| Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory. | Q47814293 | ||
| Comparison of populations of mould species in homes in the UK and USA using mould-specific quantitative PCR. | Q54643448 | ||
| Indoor air quality in two French hospitals: Measurement of chemical and microbiological contaminants | Q57100887 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P433 | issue | Supplement_2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | infection | Q166231 |
| respiratory tract infection | Q754447 | ||
| environment | Q2249676 | ||
| Aspergillus | Q335130 | ||
| respiratory tract | Q13400765 | ||
| infectious disease | Q18123741 | ||
| mycobiome | Q24975941 | ||
| P304 | page(s) | S145-S154 | |
| P577 | publication date | 2019-04-01 | |
| P1433 | published in | Medical Mycology | Q6806389 |
| P1476 | title | The human lung and Aspergillus: You are what you breathe in? | |
| P478 | volume | 57 |
| Q99365870 | Early life microbial exposures and allergy risks: opportunities for prevention |
| Q89930597 | Respiratory mycobiome and suggestion of inter-kingdom network during acute pulmonary exacerbation in cystic fibrosis |
| Q99413079 | Type 2-high asthma is associated with a specific indoor mycobiome and microbiome |
Search more.